A simple pressure pump, made from balloons and nylon stockings, means more people in more places will be able to test water contaminants and blood samples.
The ingenious device unveiled in the prestigious Lab on a Chip journal cost just $2 to make, yet works almost as well as its expensive and cumbersome lab counterparts.
Pumps are used to make biological samples flow through microfluidic devices while their contents are identified beneath a microscope.
This DIY pump came from a collaboration between researchers at RMIT University and the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia, who demonstrated its viability in tests to detect aquatic parasites and cancer cells and to study vascular diseases.
Inspired by football
Study lead author and RMIT engineer, Dr Peter Thurgood,said the team took inspiration for the simple invention from footballs, which hold large pressures when reinforced.
“We started with basic latex balloons, then realised that regular stockings made from nylon and elastane could be a perfect match to reinforce them, allowing them to hold significantly higher pressure and function as pumps,” Thurgood said.
“By simply wrapping three layers of stockings around the latex balloon we were able to increase its internal pressure by a factor of 10 – enough to run many water or blood analyses that would usually require large, expensive pumps.”
Experiments showed the reinforced balloon pump could be used to operate microfluidic devices for several hours without a significant pressure loss.
The pump also fits easily within an incubator and can be left overnight.
A low-cost field tool where it’s needed most
Study co-author and parasitologist at the Walter and Eliza Hall Institute,Associate Professor Aaron Jex, is a leading researcher in global water quality and public health interventions.
He said this simple innovation opened exciting opportunities in field water testing and the ability to test and diagnose patients for infectious pathogens and aquatic micro-organisms at the point-of-care.
“Parasitic micro-organisms have a major impact in impoverished communities in tropical and subtropical regions globally, but also in developed countries including Australia,” Jex said.
“In order to address this there is an urgent need for field-based, low-cost diagnostic tools that work in challenging, sometimes remote and often complex environments very different from a pristine laboratory.”
“As simple as it may look, this device suits those needs really well and could have a big impact.”
Co-author and RMIT biologist, Dr Sara Baratchi, said it also had promising applications for early diagnosis of diseases at home or in the doctor’s surgery.
The balloon pump was tested as a point-of-care diagnostic device for detection of very low concentrations of target cancer cells in liquid samples, and found to work.
“The hydrodynamic force of liquid produced by the reinforced balloon was enough to isolate cells for study, which was really amazing for a $2 pump!”
Baratchi is now working on applying the simplified pump technology to develop organ-on-chip systems that mimic the flow conditions in dysfunctional vessels, to better understand diseases like atherosclerosis that lead to heart attack and stroke.
An opportunity for outreach
RMIT engineer and project leader, Dr Khashayar Khoshmanesh,is a leading researcher in the field of microfluidic based lab-on-a-chip technologies.
He said while microfluidics had made significant progress over the past decade, their widespread application had been limited by the cost and bulk of pumps required to operate them.
“Simplicity is at the heart of our entire research program. By redesigning sophisticated microfluidic devices into simplified ones, we can maximise their outreach and applications for use in teaching or research in the field, not just in sophisticated labs,” he said.
“We envisage these types of pumps also being suitable for student classwork experiments to support capability development in this important area of research from an earlier stage.”
The Latest on: Point-of-care diagnostic device
via Google News
The Latest on: Point-of-care diagnostic device
- As deadly Wuhan coronavirus spreads, UCSF working on potential diagnosticon January 24, 2020 at 9:14 am
A UCSF lab believes it has found a hand-held test to quickly diagnosis the killer coronavirus that has made its way from China to the U.S.
- Heska To Acquire Scil Animal Care For Europe Expansionon January 24, 2020 at 8:28 am
Heska said it will acquire scil animal care company for $125 million in cash. Scil sells a wide range of veterinary point of care diagnostic hardware and software devices in Europe. With the deal, ...
- COPD Devices Gain Regulatory Go-Ahead: 3 Stocks in Focuson January 24, 2020 at 4:59 am
Growth in the COPD devices market can be attributed to factors like steadily rising geriatric population, increasing incidence of smoking and chronic respiratory diseases.
- Microfluidic Devices Market Analysis by Top Companies, New Technology, Demand and Opportunity Analysison January 24, 2020 at 1:19 am
In addition to this, diagnostic companies ... have launched various point of care products that are based on microfluidic technology in the past few years. This, in turn, is expected to drive the ...
- Point-of-Care Cholesterol Monitoring Device Market Is Expected to Grow at a CAGR of 2.6% by the End of 2028on January 23, 2020 at 10:56 am
End user analysis offered in the point of care cholesterol monitoring device market report uncovers considerable product consumption by diagnostic centers, diagnostic laboratories, hospitals, and ...
- Point Of Care Diagnostics Market To Witness Rapid Growth, Likely To Attain Up To USD 40.50 Billion By 2022on January 23, 2020 at 4:22 am
Roche Diagnostics, OraSure Technologies Inc, Alere Inc., Instrumentation Laboratory, Siemens Healthcare, Trinity Biotech PLC, Danaher Corporation, Abbott Laboratories, Qiagen N.V., Johnson & Johnson, ...
- Zomedica to Focus on TRUFORMA™ Commercializationon January 23, 2020 at 2:55 am
ANN ARBOR, Mich., Jan. 23, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE:ZOM) (TSXV:ZOM), announced today that it intends to focus on the final development and commercialization of ...
- ADVANCED ENDOSCOPY DEVICES (AED) introduces the ENDOPRO Elite, the first cordless hand held high definition visualization systemon January 22, 2020 at 1:00 pm
LOS ANGELES, Jan. 22, 2020 /PRNewswire-PRWeb/ -- The ENDOPRO Elite is the world's first cordless hand held camera system designed for multispecialty point of care/office use. Clinicians can now ...
- Point of Care Diagnostics 2020-2025 by Global Physicians and Healthcare Analysis and Demandon January 22, 2020 at 10:18 am
Point of Care Diagnostics is the rising inclination of physicians and healthcare providers to use point-of-care devices owing to various advantages of these devices such as ease-of-use and rapid ...
- Mindray Launches New TE7 ACE Point-of-Care Solution to Improve Diagnostic Confidenceon January 20, 2020 at 12:06 am
SHENZHEN, China, Jan. 20, 2020 /PRNewswire/ -- Mindray Medical (SZSE: 300760), a leading global provider of medical devices and solutions, announces the release of its new Point-of-Care Ultrasound ...
via Bing News